We are pleased to announce that as of 23 December 2008 we have merged our company IMEREM GmbH with RPS, Research Pharmaceutical Services, Inc., a US based company headquartered in Fort Washington, Pennsylvania, with operations across North America and Latin America. RPS is a next generation CRO and a leading provider of integrated clinical development outsourcing solutions to the bio-pharmaceutical industry (www.rpsweb.com).

By joining the RPS family, we are now able to provide you with enhanced services that include new global solutions in addition to our current local solutions. We are committed to meeting your needs for innovative, cost-effective global clinical development solutions. The key highlights of the transaction are as follows:

• The management team of IMEREM GmbH will remain in key leadership positions with RPS.
• Our current projects will continue without any changes.
• Our ongoing quality service and commitment level will remain unchanged or will improve further.
• We now have the additional resources and capabilities to provide you with complete global services.

We are excited about achieving this milestone and the opportunity that it brings to our Employees, our Clients, and the Bio-Pharmaceutical Industry. We are looking forward to meeting with you in the near future to discuss our enhanced capabilities, our innovative and unique solutions, and our expanded global reach.